• Profile
Close

Intravesical recurrence after bladder-sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome

Urologic Oncology: Seminars and Original Investigations Apr 04, 2018

van de Kamp M, et al. - The incidence of intravesical recurrences after small cell carcinoma of the bladder (SCCB) and their management were determined. SCCB was noted to be a serious potentially lethal disease. A high percentage, even in patients with limited disease (LD)-SCCB, rapidly developed systemic disease. To control the disease, systemic therapy was more important than the type of local treatment. A reasonable alternative to major surgery could be a bladder-sparing approach. Nonetheless, isolated intravesical recurrence occurred even after many years in those surviving long enough. A long-term follow-up was suggested because salvage therapy could be successful in the majority of patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay